Facebook
Twitter
LinkedIn
ForwardMedication Management: Compliance Challenges and Integration of ISO 9001 for Evaluation and Improvement - On Demand
This activity will identify the most concerning and common medication management compliance challenges and address the issues that DNV sees in often in surveys conducted. The training will highlight the value of the ISO 9001 quality management standard, process approach and internal audits as a self-assessment tool for proactive identification of problem prone areas and effective corrective action planning. An interdisciplinary involvement approach will ensure improvement in safety across different healthcare settings.
Target Audience
This activity is intended for nurses, pharmacists, and pharmacy technicians.
Learning Objectives
Overall Learning objectives
At the conclusion of this activity, participants should be able to:
- Identify the most common medication management regulatory compliance challenges and associated requirements from DNV Healthcare hospital accreditation surveys.
- Discuss compliance challenges unique to outpatient areas and clinic settings.
- Identify key interdisciplinary involvement and approaches to compliance.
- Recall the ISO 9001 standard as it relates to performance of internal audits and the organization’s own assessment of its compliance with medication management standards, proactive identification and correction of safety issues, quality and performance improvement initiatives.
Pharmacists learning objectives
At the conclusion of this activity, pharmacists should be able to:
- Identify the most common medication management regulatory compliance challenges and associated requirements from DNV Healthcare hospital accreditation surveys.
- Discuss compliance challenges unique to outpatient areas and clinic settings.
- Identify key interdisciplinary involvement and approaches to compliance.
- Recall the ISO 9001 standard as it relates to performance of internal audits and the organization’s own assessment of its compliance with medication management standards, proactive identification and correction of safety issues, quality and performance improvement initiatives.
Pharmacy technician learning objectives
At the conclusion of this activity, pharmacy technicians should be able to:
- Identify the most common medication management regulatory compliance challenges and associated requirements from DNV Healthcare hospital accreditation surveys.
- Discuss compliance challenges unique to outpatient areas and clinic settings.
Additional Information
| Attachment | Size |
|---|---|
 Helpful Tips for Users - Vizient CE System.pdf | 134.81 KB |
Faculty
Nicole Hedeen, MBA, RT(R), CPHQ, CPSO
Standards Application and Interpretation Specialist
DNV Healthcare USA Inc.
Anne Marie Pizzi, MEd, RN, HACP-CMS
Team STEPPS Master Trainer Standards Application and Interpretation Specialist
DNV Healthcare USA Inc.
Planning committee
Gretchen Brummel, PharmD, BCPS
Pharmacy Executive Director
Vizient Center for Pharmacy Practice Excellence
Vizient, Inc.
Diana Scott, MHA, RN, CPHQ
Principal
Accreditation/Regulatory Advisory Services
Vizient, Inc.
Jackie Stokes, BS
Manager, Pharmacy Program
Vizient, Inc.
Identification, Mitigation, and Disclosure of Relevant Financial Relationships
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
Disclosure of Financial Relationships:
Absence of Relevant Financial Relationships
Vizient, Inc., Jointly Accredited for Interprofessional Continuing Education, defines companies to be ineligible as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.
No one in a position to control the content of this educational activity have relevant financial relationships with ineligible companies.
Statement of content validity
Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.
FDA off-label/unapproved usage
Faculty/Presenters are required to identify any new and evolving topics for which there is a lower/absence of evidence base. This is to ensure that our content does not advocate for, or promote, practices that are not, or not yet adequately based on current science, evidence, and clinical reasoning. Faculty/Presenters are required to disclose any discussion of (1) off-label/unapproved or investigational uses of FDA approved commercial products or devices and/or (2) products or devices not yet approved in the United States.
Disclaimer: The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.
Joint Accreditation Statement:
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Designation Statement(s):
NURSING
This activity is designated for 1.0 contact hours.
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.0 ACPE credit hours.
Universal Activity Number: JA0006103-0000-23-152-H05-P
Universal Activity Number: JA0006103-0000-23-152-H05-T
OTHER
Vizient, Inc. will award all other healthcare professionals who successfully complete the activity a Certificate of Participation. Various state license boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re- certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.
Available Credit
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Technician
- 1.00 General CE - Attendance